Skip to main content
SpringerLink
Log in

Use of Drug Kinetics in Dermis to Predict in VivoBlood Concentration After Topical Application

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To use the drug kinetics in dermis to predict the in vivo blood concentration after topical administration.

Methods. A two-step pharmacokinetic model was established. The first step was to calculate the drug input rate or flux from the skin to the systemic circulation using the drug kinetic parameters in dermis. These parameters include (a) distance over which the drug concentration declines by 50%, (b) drug concentration at the epidermal-dermal junction, and (c) minimal plateauing drug concentration in the muscle layer. These parameters were experimentally determined from the drug concentration-tissue depth profiles in the dermis, after the application of a topical dose of ddI (200 mg/kg) to rats. The second step was to use the drug input rate together with the systemic disposition pharmacokinetics of ddI in rats to predict the plasma concentration-time profiles. The model-predicted plasma concentration-time profiles were compared with the observed profiles, to determine the validity of the proposed pharmacokinetic model.

Results. The observed steady state concentration (Css) in individual animals (n = 6) deviated from the predicted values by 3 to 55% with 3 of 6 rats showing a <15% deviation. The mean observed Css of all animals deviated from the mean predicted values by less than 15%.

Conclusions. The close agreement between the observed and the model-predicted drug concentrations indicates that the systemic drug input can be calculated from the drug kinetics in the dermis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. C. Williams and B. W. Barry. Skin absorption enhancer. Critical Rev. Therap. Drug Carrier Systems 9:305–353 (1992).

    Google Scholar 

  2. R. H. Guy and J. Hadgraft. Mathematical models of percutaneous absorption. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous absorption, Marcel Dekker, Inc. New York, 1989, pp. 13–26.

    Google Scholar 

  3. N. L. Benowitz, P. Jacob, P. Olsson, and C.-J. Johansson. Intravenous nicotine retards transdermal absorption of nicotine: Evidence of blood flow-limited percutaneous absorption. Clin. Pharmacol. Ther. 52:223–230, 1992.

    Google Scholar 

  4. L. K. Pershing, S. Huether, R. L. Conklin, and G. G. Krueger. Cutaneous blood flow and percutaneous absorption: a quantitative analysis using a laser doppler velocimeter and a blood flow meter. J. Invest. Dermatol. 92:355–359 (1989).

    Google Scholar 

  5. J. E. Riviere and P. L. Williams. Pharmacokinetic implication of changing blood flow in skin. J. Pharm. Sci. 81:601–602 (1992).

    Google Scholar 

  6. P. Singh and M. S. Roberts. Blood flow measurements in skin and underlying tissues by microsphere method: application to dermal pharmacokinetics of polar nonelectrolytes. J. Pharm. Sci. 82:873–879 (1993).

    Google Scholar 

  7. M. F. Flessner, R. L. Dedrick, and J. S. Schultz. A distributed model of peritoneal-plasma transport analysis of experimental data in the rat. Am. J. Physiol. 241:F413–F424 (1985).

    Google Scholar 

  8. M. G. Wientjes, J. T. Dalton, R. A. Badalment, J. R. Drago, and J. L.-S. Au. Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res. 51:4347–4354 (1991).

    Google Scholar 

  9. E. Gupta, M. G. Wientjes, and J. L.-S. Au. Penetration kinetics of 2′,3′-dideoxyinosine in dermis is described by the distributed model. Pharm. Res. 11:809–815 (1994).

    Google Scholar 

  10. B. P. Imbimbo, P. Martinelli, M. Rocchettit, G. Ferrari, G. Bassotti, and E. Imbimbo. Efficiency of different criteria for selecting pharmacokinetic multiexponential equations. Biopharm. Drug Disp. 12:139–147 (1991).

    Google Scholar 

  11. J. S. Schultz and W. Armstrong. Permeability of interstitial space of muscle (rat diaphragm) to solutes of different molecular weights. J. Pharm. Sci. 67:696–705 (1978).

    Google Scholar 

  12. E. M. Renkin. Multiple pathways of capillary permeability. Circ. Res. 41:735–751 (1977).

    Google Scholar 

  13. E. Mukherji. Delivery and pharmacodynamics of dideoxynucleosides. Doctoral Dissertation. Ohio State University, Columbus, Ohio (1993).

  14. M. Gibaldi and D. Perrier. Pharmacokinetics, Marcel Dekker, Inc., New York, 1975.

    Google Scholar 

  15. H. Schaefer and A. Zesch. Penetration of vitamin A into human skin. Acta. Derm. Venereol. 74(c):50–55 (1975).

    Google Scholar 

Download references

Authors
  1. Xiang Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Guillaume Wientjes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessie L.-S. Au
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, X., Wientjes, M.G. & Au, J.LS. Use of Drug Kinetics in Dermis to Predict in VivoBlood Concentration After Topical Application. Pharm Res 12, 2012–2017 (1995). https://doi.org/10.1023/A:1016268628647

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016268628647

Search

Navigation